isolates from this patient were less cytopathic in vitro compared with HIV-1 isolates from those patients with disease progression. The temporal association between increased viral burden and CD4+ T-cell decline suggests a direct role for HIV-1 in the cytopathology of CD4+ T cells in vivo. Our results indicate that the pathogenic mechanisms responsible for CD4+ T-cell depletion may be related to both quantitative and qualitative changes in HIV-1.
Following primary infection with human immunodeficiency virus type 1 (HIV-1), the majority of patients enter an asymptomatic period of variable duration, characterized by low levels of viral replication and relatively few clinical manifestations. In most patients, this period of clinical stability may extend for many years, although CD4+ T-cell numbers usually show a continuous gradual decline. In others, CD4+ T-cell counts decline rapidly, resulting in the onset of AIDS. To date, the underlying pathogenic mechanisms which govern the persistence of infection in vivo and ultimately the transition from low-level to fulminant infection are largely unknown.
We have previously demonstrated that infectious titers of HIV-1 in peripheral blood mononuclear cells (PBMC) and plasma are substantially higher in symptomatic patients than in asymptomatic individuals (11) . Increased levels of infectious HIV-1 or proviral DNA have also been shown by several groups in cross-sectional studies to correlate with disease status (4, 16, 22) . On the basis of limited longitudinal blood samples, Schnittman et al. (19) demonstrated an increase in viral burden in CD4+ T cells from patients with disease progression. Cumulatively, these findings suggest that increasing viral burden is associated with clinical and immunological deterioration. In other studies, progression to AIDS has been associated with the emergence of a more cytopathic viral phenotype (28) (29) (30) . It is not yet clear whether changes in viral phenotype contribute to increasing the overall viral burden or, alternatively, whether the immunological deficit that accompanies disease progression allows for selection of HIV-1 variants with increased replicative and/or cytopathic properties.
Insight into the possible pathogenic mechanisms underlying disease progression may be gained by examining the temporal relationship between changes in viral burden and phenotype, CD4+ T-cell numbers, and clinical status throughout the course of infection. To address this question, we have systematically quantified HIV-1 in sequential blood samples from four patients, three of whom exhibited a rapidly deteriorating clinical course and precipitous CD4+ T-cell decline and one of whom has remained clinically and immunologically stable 12 years after HIV-1 infection. In addition, we have evaluated the biological properties of sequential HIV-1 isolates from each of these cases to determine whether changes in viral burden and CD4+ T-cell counts are temporally associated with the emergence of a distinct viral phenotype.
MATERIALS AND METHODS
Study subjects were chosen from a cohort of 850 homosexual men monitored by the New York Blood Center since 1984 in a prospective study of AIDS (25, 26) . Many of these individuals were originally enrolled in the cohort in the late 1970s as part of a hepatitis B virus vaccine study (27) . About half of the individuals were HIV-1 seropositive when they entered the study in 1984, and one-fifth of these subsequently developed AIDS. Forty-six men seroconverted during the course of the study, and 13 of these have since progressed to AIDS. Other patients were retrospectively (Fig. 1D ). He has received no antiviral therapy for HIV-1.
Quantitative cultures of HIV-1. Aliquots of PBMC frozen in 10% dimethyl sulfoxide were thawed, and a portion of the cells were used in end-point dilution cultures (11) to determine the infectious titer of HIV-1. PBMC from each sample were serially diluted fourfold (in replicates of 4 to 10) and cocultured with 2 x 106 phytohemagglutinin-stimulated nor-VOL. 67, 1993 mal donor PBMC in 1.5 ml of growth medium consisting of RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum, penicillin (100 U/ml), streptomycin (100 ug/rml), and interleukin-2 (IL-2; 10 U/ml). The (Fig.  1A) showed a marked increase (up to 260-fold), which was concurrent with a sharp decline in CD4+ T-cell counts. A similar inverse relationship between viral load and CD4+ T-cell numbers was observed for patients B and C (Fig. 1B  and C ). In these two cases, however, the rise in HIV-1 levels generally preceded the marked decline in CD4+ T cells.
Infectious titers of HIV-1 in PBMC samples taken early in infection from patients A to C ranged from <1 to 300 TCID50 per 106 CD4+ T cells (Fig. 1) , consistent with our previous findings in asymptomatic patients (11) . Subsequently, in the period leading up to and including CD4+ T-cell decline, infectious titers rose substantially, reaching peak levels of 3,000 to 10,000 TCID50 per 106 CD4+ T cells. Parallel results were obtained by quantitative PCR methods. Over the same time period, the number of HIV-1 DNA copies increased dramatically in all three patients, reaching peak levels between 6,000 and 23,000 copies per 106 CD4+ T cells (Fig. 1A  to C) .
In contrast, culture and PCR quantitation of HIV-1 in sequential PBMC samples from patient D revealed persistent, low levels of virus (Fig. 1D) 30 to 300 pg/ml; +, 300 to 1,000 pg/ml; ++, >1,000 pg/ml. later isolates were readily infectious in these cells (Table 1) . Similar results showing this phenotypic switch were also seen with serial isolates from patients B and C (Table 1) . In each case, a direct correlation was observed between infectivity and syncytium formation in the MT-2 cell cultures. Whereas earlier isolates from patients A to C were uniformly negative in inducing syncytia, later isolates established infection and induced syncytium formation in MT-2 cells. None of the isolates appeared to infect MT-2 cells in the absence of syncytium formation, suggesting that infectivity and syncytium formation may be related properties in these cells. As seen in Fig. 1 , the switch from non-syncytiuminducing (NSI) to syncytium-inducing (SI) phenotype occurred prior to the onset of CD4+ T-cell decline in each of these three patients. In contrast, sequential isolates from patient D were uniformly unable to infect MT-2 cells or induce syncytium formation irrespective of the time of isolation (Table 1 ; Fig. 1) .
Further experiments were done to evaluate the replicative and cytopathic capacity of isolates derived immediately before and after the NSI-to-SI phenotypic switch observed in MT-2 cells. For patient D, who had only NSI viruses, isolates were selected from two time points that were approximately 1 year apart. The results from these experiments are summarized in Fig. 2 and 3 . For patients A to C, whose viruses exhibited an NSI-to-SI switch, the SI phenotype was in each case associated with higher levels of HIV-1 replication ( Fig. 2A to C ) and increased cytopathicity (Fig.  3A to C) in CD4-enriched PBMC cultures compared with the paired NSI isolate. In addition, SI isolates from patients A to C generally replicated to higher levels than did NSI isolates from patient D (Fig. 2D) . Quantitation of cell viability by trypan blue dye exclusion demonstrated increased cell death in CD4-enriched PBMC cultures infected with SI isolates from patients A to C compared with cultures infected with paired NSI isolates (Fig. 3A to C) . The predominant cytopathic effect was not related to syncytium formation, however, since relatively few multinucleated cells were observed. No difference in the level of cytopathicity was seen with paired NSI isolates from patient D (Fig. 3D) .
DISCUSSION
In this study, we have quantified the levels of HIV-1 in serial samples from four HIV-1-infected individuals. Three of these patients had a precipitous drop in CD4+ T cells followed by rapid progression to AIDS. A significant increase was seen in the levels of HIV-1 concurrent with or prior to the CD4+ T-cell decline in these patients (Fig. 1) . This is the first demonstration of a direct association between viral burden and CD4+ T-cell numbers in a detailed longitudinal study. Our findings suggest that a burst of viral replication may occur prior to or at the onset of CD4+ T-cell decline. Fig. 2 and 3 ). Taken together, these observations support a central role for HIV-1 in CD4+ T-cell depletion in vivo.
In vitro correlates of HIV-1 pathogenicity have been associated in previous studies with clinical status (1, 2, 7, 28, 30) . Isolates from patients with late-stage disease frequently acquire an expanded host cell range and increased cytopathicity in vitro when compared with isolates from asymptomatic individuals (1, 7, 21, 29) . In sequential determinations of host cell range in vitro, we found no difference in the ability of early and late isolates from four HIV-1-infected patients to establish productive infection in primary cultures of normal donor PBMC or macrophages. In each case, high levels of supernatant HIV-1 p24 antigen were detected within 1 week of inoculation, indicating efficient viral entry and replication in these cells.
Conversely, none of the isolates tested was able to infect H9 or HPB-ALL cells within the same time period. When a more permissive T-cell line (MT-2) was used, however, clear distinctions were seen in the ability of sequential isolates to establish productive infection (Table 1 ). In three of the patients, infectivity in MT-2 cells in vitro was directly associated with the rapid onset of CD4+ T-cell decline. One possibility suggested by these findings is that variants of HIV-1 that are more efficient at mediating entry into susceptible cells may emerge during the course of infection, thus giving rise in part to an increase in the overall viral burden.
The temporal association between increased viral burden and CD4+ T-cell decline suggests a direct role for HIV-1 in mediating cytopathology of CD4+ T-cells in vivo. The cytopathic effects of HIV-1 infection in T cells in vitro include syncytium formation (12, 15, 23) and single-cell killing (3, 23, 24) , which is a typical feature of many primary patient isolates. In the present study, we observed a marked transition to an SI phenotype in sequential HIV-1 isolates from patients with clinical progression and CD4+ T-cell depletion, consistent with an earlier report by Tersmette et al. (29) . Interestingly, SI isolates from patients with clinical progression also had increased levels of single-cell killing and enhanced viral replication in CD4-enriched PBMC cultures compared with paired NSI isolates. It is possible that this shift in pathogenicity may also reflect an increase in the replicative and cytopathic properties of the virus in vivo.
These results are further supported by the finding that similar changes in viral replication and cytopathicity did not occur with HIV-1 isolates from the one patient who has remained clinically stable. This patient has been HIV-1 seropositive for at least 12 years and has consistently maintained a low viral burden and normal CD4+ T-cell counts. Continued studies on similarly stable patients will be important for identifying specific viral and/or host factors associated with long-term survival.
Previous studies have suggested that increased levels of HIV-1 may be triggered by exogenous factors, including coinfection with other pathogens, immunizations, or transfusions (6, 9) . No clinical events were identified in the patients studied here to suggest that such exogenous factors played a role in stimulating HIV-1 replication during the critical period. However, this possibility cannot be formally ruled out.
Increases in viral burden over time may also reflect the emergence of HIV-1 variants that escape immune surveillance (13) . The high mutation rate of certain HIV-1 genes, coupled with immune selective pressures, may give rise to HIV-1 genotypic variants with altered antigenicity at viral determinants important for recognition by neutralizing antibodies or cytotoxic T lymphocytes. Longitudinal studies are now in progress in our laboratory to determine whether escape mutants emerge during the course of infection and whether they are associated with higher levels of HIV-1 and subsequent disease progression.
Overall, our findings suggest that the underlying pathogenic mechanisms responsible for CD4+ T-cell decline are related to both quantitative and qualitative changes in HIV-1. Increased viral load coupled with increased virulence may have a multiplicative or synergistic effect, resulting in the rapid and profound depletion of CD4+ T lymphocytes observed in three of our cases. Disruption of immune function at the time of CD4+ T-cell decline may further contribute to the establishment of a high viral burden by allowing for selection of HIV-1 variants with increased replicative and cytopathic properties. While most HIV-1-infected individuals have a more gradual decrease in their CD4+ T-cell counts, it is possible that the same pathogenic mechanisms will apply. 
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